Asztma: vizsgálatok itt: Románia
14 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of QMF149 (Indacaterol Acetate/Mometasone Furoate) Versus Budesonide in Children From 6 to Less Than 12 Years of Age With Asthma
- Where
- Bucharest
- Életkor
- 6 év to 11 év
- People
- 200 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT05562466 · EU 2022-501899-26-00 - 3. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of QVM149 (Indacaterol Acetate / Glycopyrronium Bromide / Mometasone Furoate) Versus Salmeterol Xinafoate/Fluticasone Propionate in Children From 12 Years to Less Than 18 Years of Age With Asthma.
- Where
- Bucharest
- Életkor
- 12 év to 17 év
- People
- 188 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT05776927 - 3. fázisTaking peopleA Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma
- Where
- Bucharest
- Életkor
- 5 év to 11 év
- People
- 231 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06023589 - 3. fázisTaking peopleA Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)
- Where
- Brasov, Bucharest, Cluj-Napoca, Craiova, Oradea, Timisoara, Timis
- Életkor
- 12 év to 80 év
- People
- 786 worldwide
- Run by
- Generate Biomedicines
See details and how to joinNCT07276724 · EU 2025-521950-41-00 - 1. fázisTaking peopleA Study to Compare the Relative Potency of Salbutamol Administered Via Metered Dose Inhalers (MDI) Containing Propellants HFA-152a to HFA-134a in Mild Asthmatics Aged 18 to 65 Inclusive
- Where
- Bucharest, Cluj-Napoca
- Életkor
- 18 év to 65 év
- People
- 84 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT06433921 · EU 2024-511220-14-00 - 2. fázisTaking peopleA Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma
- Where
- Brasov, Craiova, Timișoara
- Életkor
- 18 év to 75 év
- People
- 264 worldwide
- Run by
- Kymera Therapeutics, Inc.
See details and how to joinNCT07323654 - 2. fázisNot yet taking people in RomániaA Long-term Study of KT-621 Administered Orally to Participants with Asthma Previously Enrolled in a KT-621 Asthma Study
- Where
- Brasov, Craiova, Timisoara
- Életkor
- 18 év and over
- People
- 77 worldwide
- Run by
- Kymera Therapeutics Inc.
See details and how to join2026-526241-98-00 · EU 2026-526241-98-00 - 2. fázisTaking peopleA Study of KT-621 Administered Orally to Adult Participants with Moderate to Severe Eosinophilic Asthma
- Where
- Brasov, Craiova, Timisoara
- Életkor
- 18 év and over
- People
- 121 worldwide
- Run by
- Kymera Therapeutics Inc.
See details and how to join2025-523180-38-00 · EU 2025-523180-38-00 - 3. fázisTaking peopleA Study of Efficacy and Safety of Depemokimab Compared With Placebo in Adults and Adolescents With at Risk Type 2 Asthma
- Where
- Brasov, Bucharest, Craiova
- Életkor
- 12 év and over
- People
- 456 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT07456033 · EU 2025-524463-20-00 - 3. fázisTaking peopleA double-dummy, double-blind, randomized, active controlled, two-way cross-over study with 12-week treatment duration per period, to evaluate the efficacy and safety of QVM149 (indacaterol acetate / glycopyrronium bromide / mometasone furoate) compared to salmeterol xinafoate/fluticasone propionate in children from 12 years to less than 18 years of age with asthma.
- Where
- Bucharest
- Életkor
- Up to 17 év
- People
- 68 worldwide
- Run by
- Novartis Pharma AG
See details and how to join2022-502365-26-00 · EU 2022-502365-26-00 - 4. fázisTaking peopleBETRI-Prospective: Asthma Control in Single Inhaler ICS/LABA/LAMA (87/5/9 pMDI [BDP/FF/GB - 100/6/12.5 μg]) vs Single Inhaler ICS/LABA (200/6 pMDI [BDP/FF - 200/6 μg])
- Where
- Bragadiru, Bucharest, Cluj-Napoca, Craiova, Iasi, Timisoara
- Életkor
- 18 év and over
- People
- 644 worldwide
- Run by
- Chiesi Farmaceutici S.p.A.
See details and how to joinNCT07666490 · EU 2025-524289-56-00 - 2. fázisTaking peopleA Clinical Study to Evaluate the Efficacy and Safety of Frevecitinib (KN-002) in Patients With Severe Asthma
- Where
- Craiova
- Életkor
- 18 év to 75 év
- People
- 512 worldwide
- Run by
- Kinaset Therapeutics Inc
See details and how to joinNCT07532265 · EU 2023-509125-41-00 - 2. fázisTaking peopleTherapeutic Equivalence of CHF5993 pMDI 100/6/12.5 µg HFA-152a in Subjects With Mild to Moderate Asthma
- Where
- Bacau, Bragadiru, Brasov, Bucaresti, Bucharest, Cluj-Napoca, Craiova, Deva, Oradea, Timisoara, Timișoara
- Életkor
- 18 év to 75 év
- People
- 780 worldwide
- Run by
- Chiesi Farmaceutici S.p.A.
See details and how to joinNCT07301736 · EU 2025-521456-35-00 - No phaseNot yet taking people in RomániaDesign, Development and Evaluation of a Digital Health Assistant for Paediatric Asthma
- Where
- Brasov, Bucharest, Suceava, Timișoara
- Életkor
- 10 év to 19 év
- People
- 42
- Run by
- University Children's Hospital Basel
See details and how to joinNCT07472283